Atomi Financial Group Inc. Has $590,000 Position in Colgate-Palmolive (NYSE:CL)

Atomi Financial Group Inc. boosted its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 6,489 shares of the company’s stock after buying an additional 394 shares during the quarter. Atomi Financial Group Inc.’s holdings in Colgate-Palmolive were worth $590,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CL. XTX Topco Ltd acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $423,000. Evergreen Capital Management LLC lifted its position in shares of Colgate-Palmolive by 4.2% in the second quarter. Evergreen Capital Management LLC now owns 3,490 shares of the company’s stock valued at $339,000 after buying an additional 141 shares during the last quarter. AlTi Global Inc. lifted its position in shares of Colgate-Palmolive by 2.9% in the second quarter. AlTi Global Inc. now owns 4,281 shares of the company’s stock valued at $415,000 after buying an additional 119 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Colgate-Palmolive by 58.6% in the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock valued at $234,540,000 after buying an additional 892,706 shares during the last quarter. Finally, APG Asset Management N.V. lifted its position in shares of Colgate-Palmolive by 64.3% in the second quarter. APG Asset Management N.V. now owns 1,251,422 shares of the company’s stock valued at $113,308,000 after buying an additional 489,977 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 0.5 %

Shares of CL stock opened at $87.98 on Friday. The stock’s fifty day moving average price is $92.00 and its two-hundred day moving average price is $97.58. The company has a market cap of $71.88 billion, a PE ratio of 25.21, a P/E/G ratio of 3.62 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $80.03 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CL shares. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday, January 17th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.